Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about DJ-1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
DJ-1 (PARK7) protein: structure, function, and role in Parkinson's disease and oxidative stress response
No AI portrait yet
| Gene Symbol | DJ |
| Function | Dj 1 Protein (Park7) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes. |
| GeneCards | DJ |
| Human Protein Atlas | DJ |
| Associated Diseases | Aging, Als, Alzheimer, Ataxia, disease |
| Interactions | 6-OHDA, ACSL4, Alpha-Synuclein, ALPHA-SYNUCLEIN, ALZHEIMER, ALZHEIMER'S DISEASE |
| KG Connections | 597 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
DJ_1["DJ-1"]
DJ_1 -.protects against.-> Dementia["Dementia"]
DJ_1 -->|"regulates"| mitochondrial_function["mitochondrial function"]
DJ_1 -->|"activates"| Nrf2["Nrf2"]
DJ_1 -->|"target for"| Parkinson["Parkinson"]
DJ_1 -->|"target for"| Ms["Ms"]
DJ_1 -->|"target for"| Neurodegeneration["Neurodegeneration"]
DJ_1 -->|"target for"| Aging["Aging"]
DJ_1 -->|"interacts"| Als["Als"]
DJ_1 -->|"activates"| Alzheimer["Alzheimer"]
NRF2["NRF2"] -->|"activates"| DJ_1
PARKINSON_S_DISEASE["PARKINSON'S DISEASE"] -->|"target for"| DJ_1
PINK1["PINK1"] -->|"activates"| DJ_1
ALPHA_SYNUCLEIN["ALPHA-SYNUCLEIN"] -->|"target for"| DJ_1
NEURODEGENERATION["NEURODEGENERATION"] -->|"target for"| DJ_1
PARKIN["PARKIN"] -->|"activates"| DJ_1
LRRK2["LRRK2"] -->|"target for"| DJ_1
POLG["POLG"] -->|"target for"| DJ_1
MITOCHONDRIAL_DYSFUNCTION["MITOCHONDRIAL DYSFUNCTION"] -->|"target for"| DJ_1
PTEN["PTEN"] -->|"activates"| DJ_1| Target | Relation | Type | Str |
|---|---|---|---|
| Parkinson | associated_with | disease | 0.85 |
| Ferroptosis | inhibits | process | 0.85 |
| brain-derived extracellular vesicles | expressed_in | compound | 0.80 |
| Dementia | protects_against | disease | 0.80 |
| Oxidative Stress Response | regulates | process | 0.78 |
| Parkinson | expressed_in | disease | 0.75 |
| Parkinson | therapeutic_target | disease | 0.75 |
| Microglial Autophaxy and Phagocytosis | contributes_to | process | 0.75 |
| Chaperone | regulates | pathway | 0.70 |
| Mitochondrial Homeostasis | regulates | process | 0.70 |
| mitochondrial function | regulates | process | 0.70 |
| mitochondrial dysfunction | associated_with | process | 0.70 |
| Nrf2 | activates | transcription_factor | 0.70 |
| Parkinson's disease | associated_with | disease | 0.70 |
| Oxidative Stress | regulates | pathway | 0.70 |
| LRRK2 | associated_with | gene | 0.70 |
| PARKINSON | activates | gene | 0.70 |
| PARKIN | associated_with | gene | 0.70 |
| ALS | associated_with | disease | 0.65 |
| Tumor | activates | disease | 0.65 |
| Neurodegeneration | activates | disease | 0.65 |
| ALS | regulates | disease | 0.65 |
| Alzheimer | inhibits | disease | 0.65 |
| Neurodegeneration | associated_with | disease | 0.65 |
| Neuroinflammation | associated_with | disease | 0.65 |
| Ms | inhibits | disease | 0.65 |
| Parkinson | protects_against | disease | 0.65 |
| Depression | inhibits | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| Neurodegeneration | protects_against | disease | 0.65 |
| Inflammation | associated_with | disease | 0.65 |
| Neurodegeneration | regulates | disease | 0.65 |
| Parkinson | biomarker_for | disease | 0.65 |
| Alzheimer | treats | disease | 0.65 |
| Als | inhibits | disease | 0.65 |
| Neurodegeneration | biomarker_for | disease | 0.65 |
| Huntington | associated_with | disease | 0.65 |
| Depression | treats | disease | 0.65 |
| Parkinson | regulates | disease | 0.65 |
| Als | biomarker_for | disease | 0.65 |
| Tumor | expressed_in | disease | 0.65 |
| Cancer | therapeutic_target | disease | 0.65 |
| Ataxia | associated_with | disease | 0.65 |
| Als | interacts_with | disease | 0.65 |
| ALS | activates | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Ms | expressed_in | disease | 0.65 |
| Neurodegeneration | therapeutic_target | disease | 0.65 |
| Aging | therapeutic_target | disease | 0.65 |
| Inflammation | activates | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| HIF-1Α/SIMA | interacts_with | protein | 0.80 |
| PARKINSON | associated_with | gene | 0.80 |
| OXIDATIVE STRESS | regulates | gene | 0.70 |
| PARKINSON'S DISEASE | associated_with | gene | 0.70 |
| PARKINSON'S DISEASE | therapeutic_target | gene | 0.70 |
| PARKINSON | expressed_in | gene | 0.70 |
| PPAR | activates | gene | 0.70 |
| PARKINSON'S DISEASE | expressed_in | gene | 0.70 |
| TNF-Α | activates | gene | 0.60 |
| MICROGLIA | activates | gene | 0.60 |
| PGK1 | expressed_in | gene | 0.60 |
| GAIN | expressed_in | gene | 0.60 |
| PRKN | associated_with | gene | 0.60 |
| SNCA | associated_with | gene | 0.60 |
| PKC | associated_with | gene | 0.60 |
| OVERVIEW | associated_with | gene | 0.60 |
| AMPK | associated_with | gene | 0.60 |
| CDK5 | associated_with | gene | 0.60 |
| RET | associated_with | gene | 0.60 |
| ATM | associated_with | gene | 0.60 |
| PARKIN | therapeutic_target | gene | 0.60 |
| MITOCHONDRIA | therapeutic_target | gene | 0.60 |
| PARKIN | activates | gene | 0.60 |
| LRRK2 | therapeutic_target | gene | 0.60 |
| POLG | therapeutic_target | gene | 0.60 |
| MITOCHONDRIAL DYSFUNCTION | therapeutic_target | gene | 0.60 |
| PTEN | activates | gene | 0.60 |
| SNCA | therapeutic_target | gene | 0.60 |
| PINK1 | interacts_with | gene | 0.60 |
| ALPHA-SYNUCLEIN | interacts_with | gene | 0.60 |
| PARKIN | interacts_with | gene | 0.60 |
| UBIQUITIN | therapeutic_target | gene | 0.60 |
| MITOPHAGY | therapeutic_target | gene | 0.60 |
| LRRK2 | interacts_with | gene | 0.60 |
| OXIDATIVE STRESS | interacts_with | gene | 0.60 |
| ALPHA-SYNUCLEIN | regulates | gene | 0.60 |
| APOPTOSIS | expressed_in | gene | 0.60 |
| CANCER | therapeutic_target | gene | 0.60 |
| PINK1 | associated_with | gene | 0.60 |
| NEURODEGENERATION | associated_with | gene | 0.60 |
| NEURODEGENERATIVE DISORDERS | implicated_in | gene | 0.60 |
| GENES | associated_with | gene | 0.60 |
| ALZHEIMER'S DISEASE | implicated_in | gene | 0.60 |
| NEURODEGENERATIVE DISEASES | activates | gene | 0.60 |
| ROS | inhibits | gene | 0.60 |
| NEURODEGENERATION | protects_against | gene | 0.60 |
| PARKINSON'S DISEASE | protects_against | gene | 0.60 |
| PARKINSON | protects_against | gene | 0.60 |
| MITOCHONDRIA | inhibits | gene | 0.60 |
| HIF-1Α | regulates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning DJ-1 in their description or question text
No additional research found